Seminar “Bringing a drug product to the market: from pre-clinical to registration. Practicalities.”

Seminar “Bringing a drug product to the market: from pre-clinical to registration. Practicalities.”

,

OCT in joint with the Cluster for Biological and Medical Technology of the Skolkovo Fund are organizing a seminar devoted to the process of bringing medicinal products to the Russian market, starting with pre-clinical studies conduct and resulting in marketing authorization of the drug. This seminar is aimed to inform participants in a detailed way about the up-to-date approaches and peculiarities of the process of medicinal products in-vitro and in-vivo research and drug registration in Russia.

This seminar will be extremely useful for both representatives of the pharmaceutical and biotechnology companies, and the biomedical start-ups which plan to bring their own medicinal products to the Russian market and are in need for a detailed description of the whole process and advice on their projects. During the seminar all the participants will have opportunities to ask concrete questions of their prime interest and discuss situations they face in their everyday lives.

OCT will be represented by the experienced specialists from the clinical operations department – Irina Petrova, Head of Clinical Operations, Evgeniya Radkova, Medical Writer; quality assurance department - Maria Zaitseva, Quality Manager; data management and statistics department – Kristina Leus, Director of Data Matrix*.

To participate in the event, please contact

Anna Yanaeva, 
Business Development, Associate 
ayanaeva@oct-clinicaltrials.com

*Data Matrix is a subsidiary in OCT Group Holding